![]() ![]() Novo on Thursday reported earnings before interest and taxes (EBIT) of 25 billion Danish crowns ($3.72 billion), above an average analyst forecast of 22.4 billion, according to a Refinitiv poll.Įarlier this month, Novo, the second-most valuable company in Europe by market capitalisation behind French luxury goods group LVMH, significantly raised its full-year operating profit and sales expectations on the back of strong demand for Wegovy. We are not commenting on specific launch dates,' he said. 'We will gradually roll out in International Operations, and UK is a part of that. Jorgensen said he could not give a date for when Wegovy would be launched in the UK, where in March the country's cost effectiveness watchdog recommended it for use for certain obese people. Last month the company said a second contract manufacturer would commence production of Wegovy and on Thursday Jorgensen said a third manufacturer would begin production later this year. Supply of starter doses in the US would be cut by around 50 percent for 'some months', Mr Jorgensen added.Ĭredit Suisse analysts said they were not surprised by the move, given the level of demand for the drug. Analysts said more than half of these were new.Ĭhief executive Lars Jorgensen told journalists on Thursday: 'We cannot supply an uptake that just continues growing, so it's important for us that we secure continuity of supply for those patients who have started treatment.' ![]() More than five million Americans received a prescription for Ozempic in 2022, data shows, compared to 230,000 in 2019.Īnd the number is only growing, with more than 373,000 prescriptions filed in the last week of February alone, double the number from the same time last year. Sales of Novo's obesity care products, including Wegovy, rose 124 percent in the first quarter. Novo has faced supply constraints for its hugely popular Wegovy drug as a result of overwhelming demand, and has invested massively in increasing supply. Novo said in a statement: 'To safeguard continuity of care, the supply of the lower Wegovy dose strengths in the US will be reduced temporarily.' ![]() Ozempic and Wegovy have become increasingly popular thanks to celebrity endorsements and social media (file photo) ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |